Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells

T. Moritz, H. Hanenberg, I. Katrf, P. A. Williams

Research output: Contribution to journalArticle

Abstract

Hematopoietic stem cells are important targets for genetic modification with retroviral vectors. However, attempts to establish protocols applicable for human gene therapy of stem cells have achieved limited success due in part to low gene transfer efficiency. We have shown that exposure of target cells to chymotryptic or recombinant fragments of the extracellular matrix molecule fibronectin during the transduction protocol increases retrovirusmediated gene transfer into hematopoietic stem and progenitor cells without the need for co-culture on the producer cells. The mechanism of this enhanced gene transfer into target cells is at least partly due to direct binding of retroviral particles to sequences within the fibronectin molecule. Transduction of mammalian cells is greatly enhanced when cells are adherent to chimeric fibronectin fragments which contain binding sites for either VLA-4 or VLA-5 integrins expressed on various target cells in combination with these retroviral binding sequences. Furthermore, we suggest that co-localization of retrovirus and cells on fibronectin peptides should allow targeted transduction of specific cell types by exploiting unique ligang/ receptor interactions. This mechanism may have implications not only for retroviral vectors, but also for natural retroviral infection.

Original languageEnglish
Pages (from-to)1060
Number of pages1
JournalExperimental Hematology
Volume24
Issue number9
StatePublished - 1996

Fingerprint

Fibronectins
Genes
Hematopoietic Stem Cells
Integrin alpha5beta1
Integrin alpha4beta1
Retroviridae
Coculture Techniques
Integrins
Genetic Therapy
Extracellular Matrix
Stem Cells
Binding Sites
Peptides
Infection

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

Moritz, T., Hanenberg, H., Katrf, I., & Williams, P. A. (1996). Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells. Experimental Hematology, 24(9), 1060.

Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells. / Moritz, T.; Hanenberg, H.; Katrf, I.; Williams, P. A.

In: Experimental Hematology, Vol. 24, No. 9, 1996, p. 1060.

Research output: Contribution to journalArticle

Moritz, T, Hanenberg, H, Katrf, I & Williams, PA 1996, 'Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells', Experimental Hematology, vol. 24, no. 9, pp. 1060.
Moritz, T. ; Hanenberg, H. ; Katrf, I. ; Williams, P. A. / Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells. In: Experimental Hematology. 1996 ; Vol. 24, No. 9. pp. 1060.
@article{2a72dd2aa0da4f419382aa911095352f,
title = "Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells",
abstract = "Hematopoietic stem cells are important targets for genetic modification with retroviral vectors. However, attempts to establish protocols applicable for human gene therapy of stem cells have achieved limited success due in part to low gene transfer efficiency. We have shown that exposure of target cells to chymotryptic or recombinant fragments of the extracellular matrix molecule fibronectin during the transduction protocol increases retrovirusmediated gene transfer into hematopoietic stem and progenitor cells without the need for co-culture on the producer cells. The mechanism of this enhanced gene transfer into target cells is at least partly due to direct binding of retroviral particles to sequences within the fibronectin molecule. Transduction of mammalian cells is greatly enhanced when cells are adherent to chimeric fibronectin fragments which contain binding sites for either VLA-4 or VLA-5 integrins expressed on various target cells in combination with these retroviral binding sequences. Furthermore, we suggest that co-localization of retrovirus and cells on fibronectin peptides should allow targeted transduction of specific cell types by exploiting unique ligang/ receptor interactions. This mechanism may have implications not only for retroviral vectors, but also for natural retroviral infection.",
author = "T. Moritz and H. Hanenberg and I. Katrf and Williams, {P. A.}",
year = "1996",
language = "English",
volume = "24",
pages = "1060",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "9",

}

TY - JOUR

T1 - Fibronecttn improves retroviral gene transfer by colocalizing vector and target cells

AU - Moritz, T.

AU - Hanenberg, H.

AU - Katrf, I.

AU - Williams, P. A.

PY - 1996

Y1 - 1996

N2 - Hematopoietic stem cells are important targets for genetic modification with retroviral vectors. However, attempts to establish protocols applicable for human gene therapy of stem cells have achieved limited success due in part to low gene transfer efficiency. We have shown that exposure of target cells to chymotryptic or recombinant fragments of the extracellular matrix molecule fibronectin during the transduction protocol increases retrovirusmediated gene transfer into hematopoietic stem and progenitor cells without the need for co-culture on the producer cells. The mechanism of this enhanced gene transfer into target cells is at least partly due to direct binding of retroviral particles to sequences within the fibronectin molecule. Transduction of mammalian cells is greatly enhanced when cells are adherent to chimeric fibronectin fragments which contain binding sites for either VLA-4 or VLA-5 integrins expressed on various target cells in combination with these retroviral binding sequences. Furthermore, we suggest that co-localization of retrovirus and cells on fibronectin peptides should allow targeted transduction of specific cell types by exploiting unique ligang/ receptor interactions. This mechanism may have implications not only for retroviral vectors, but also for natural retroviral infection.

AB - Hematopoietic stem cells are important targets for genetic modification with retroviral vectors. However, attempts to establish protocols applicable for human gene therapy of stem cells have achieved limited success due in part to low gene transfer efficiency. We have shown that exposure of target cells to chymotryptic or recombinant fragments of the extracellular matrix molecule fibronectin during the transduction protocol increases retrovirusmediated gene transfer into hematopoietic stem and progenitor cells without the need for co-culture on the producer cells. The mechanism of this enhanced gene transfer into target cells is at least partly due to direct binding of retroviral particles to sequences within the fibronectin molecule. Transduction of mammalian cells is greatly enhanced when cells are adherent to chimeric fibronectin fragments which contain binding sites for either VLA-4 or VLA-5 integrins expressed on various target cells in combination with these retroviral binding sequences. Furthermore, we suggest that co-localization of retrovirus and cells on fibronectin peptides should allow targeted transduction of specific cell types by exploiting unique ligang/ receptor interactions. This mechanism may have implications not only for retroviral vectors, but also for natural retroviral infection.

UR - http://www.scopus.com/inward/record.url?scp=33748625481&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748625481&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 1060

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 9

ER -